益生菌市場－全球產業規模、佔有率、趨勢、機會和預測，按類型、畜種、功能、劑型、地區和競爭格局分類，2020-2030年預測

2024年全球益生菌市場規模為79.4億美元，預計到2030年將以7.91%的複合年成長率成長至125.4億美元。益生菌涵蓋益生菌、益生元、有機酸和精油等成分，用於促進動物腸道菌叢平衡，進而提升動物的整體健康和生產力。市場成長的主要促進因素包括：對天然飼料添加劑的需求不斷成長、人們對畜牧業健康意識的提高以及全球對抗生素生長促進劑的監管限制。

主要市場促進因素

全球益生菌市場的成長受到抗生素生長促進劑嚴格監管的顯著影響。

主要市場挑戰

阻礙全球益生菌市場成長的一大挑戰是高昂的生產成本和複雜的監管架構。

主要市場趨勢

益生菌製劑和遞送技術的進展

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：客戶之聲

第5章：全球益生菌市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按類型（益生菌、益生元、有機酸、精油）
  • 依牲畜（家禽、豬、反芻動物、水生動物、其他）分類
  • 依功能分類（營養與腸道健康、產量、免疫力與生產）
  • 按形態（乾粉、液體）
  • 按地區
  • 按公司（2024 年）
• 市場地圖

第6章：北美益生菌市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲益生菌市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區益生菌市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲優生學市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲優生學市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章：市場動態

• 促進要素
• 挑戰

第12章：市場趨勢與發展

• 併購（如有）
• 產品發布（如有）
• 最新進展

第13章：全球益生菌市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商議價能力
• 顧客的力量
• 替代產品的威脅

第15章：競爭格局

• Novozymes A/S
• Cargill, Incorporated
• DuPont de Nemours, Inc.
• Koninklijke DSM NV
• Lallemand Inc.
• Novus International, Inc.
• Kemin Industries, Inc.
• Asahi Group Holdings, Ltd.

第16章：策略建議

第17章調查會社について,免責事項

The Global Eubiotics Market, valued at USD 7.94 Billion in 2024, is projected to grow at a CAGR of 7.91% to reach USD 12.54 Billion by 2030. Eubiotics-encompassing probiotics, prebiotics, organic acids, and essential oils-are used to promote a balanced gut microflora in animals, enhancing overall health and productivity. Market growth is primarily driven by rising demand for natural feed additives, heightened awareness of livestock health, and global regulatory restrictions on antibiotic growth promoters.

Key Market Drivers

The growth of the Global Eubiotics Market is significantly influenced by stringent regulations on antibiotic growth promoters

Global regulatory efforts to combat antimicrobial resistance are compelling livestock producers to adopt alternatives to antibiotic growth promoters, thereby accelerating demand for eubiotics. According to the European Medicines Agency's thirteenth annual ESVAC report published in November 2023, sales of veterinary antibiotics in 25 European countries declined by 53% between 2011 and 2022, creating a substantial shift toward non-antibiotic feed additives. In parallel, rising consumer preference for antibiotic-free animal products strengthens market demand. Growing awareness of antibiotic residues in meat and the public health threat of antimicrobial resistance has led consumers to favor proteins produced through natural feed solutions. The European Environment Agency reported in May 2024 that antimicrobial-resistant infections cause approximately 35,000 deaths annually in the European Economic Area, reinforcing consumer urgency. This industry momentum is further reflected in related sectors, such as dsm-firmenich's Feed Enzymes Alliance, which accounted for about €300 million in annual net sales in 2024, demonstrating strong market activity in advanced feed solutions.

Key Market Challenges

A significant challenge impeding the growth of the Global Eubiotics Market is the combination of high production costs and complex regulatory frameworks

Advanced eubiotic formulations require substantial investment in production, resulting in higher product prices that can limit adoption, especially among small and medium-sized livestock operations. This cost barrier reduces competitiveness against traditional feed additives. Additionally, stringent regulatory standards significantly increase development expenses and time-to-market. Extensive safety and efficacy testing is required for approval, further elevating costs and slowing innovation. Eurostat reported that EU gross domestic expenditure on research and development reached €389 billion in 2023, illustrating the high financial burden associated with innovation in regulated sectors such as feed additives. These combined pressures limit new product entry and restrict the market's ability to scale rapidly.

Key Market Trends

Advancements in Eubiotic Formulation and Delivery Technologies

Innovations in formulation are enabling more stable, targeted, and effective eubiotic products designed to withstand gastrointestinal conditions and deliver optimal benefits. These advancements improve nutrient absorption, gut health, and overall animal performance. In 2023, Novozymes partnered with Bactolife to commercialize Ablacto+, a biosolution aimed at improving piglet gut stability and reducing post-weaning diarrhea, highlighting the movement toward next-generation biological products.

Key Market Players

• Novozymes A/S
• Cargill, Incorporated
• DuPont de Nemours, Inc.
• Koninklijke DSM N. V.
• Lallemand Inc.
• Novus International, Inc.
• Kemin Industries, Inc.
• Asahi Group Holdings, Ltd.

Report Scope:

In this report, the Global Eubiotics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Eubiotics Market, By Type:

• Probiotics
• Prebiotics
• Organic Acids
• Essential Oils

Eubiotics Market, By Livestock:

• Poultry
• Swine
• Ruminants
• Aquatic Animals
• Others

Eubiotics Market, By Function:

• Nutrition & Gut Health
• Yield
• Immunity & Production

Eubiotics Market, By Form:

• Dry
• Liquid

Eubiotics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Eubiotics Market.

Available Customizations:

Global Eubiotics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Eubiotics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Probiotics, Prebiotics, Organic Acids, Essential Oils)
  • 5.2.2. By Livestock (Poultry, Swine, Ruminants, Aquatic Animals, Others)
  • 5.2.3. By Function (Nutrition & Gut Health, Yield, Immunity & Production)
  • 5.2.4. By Form (Dry, Liquid)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Eubiotics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Livestock
  • 6.2.3. By Function
  • 6.2.4. By Form
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Eubiotics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Livestock
      • 6.3.1.2.3. By Function
      • 6.3.1.2.4. By Form
  • 6.3.2. Canada Eubiotics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Livestock
      • 6.3.2.2.3. By Function
      • 6.3.2.2.4. By Form
  • 6.3.3. Mexico Eubiotics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Livestock
      • 6.3.3.2.3. By Function
      • 6.3.3.2.4. By Form

7. Europe Eubiotics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Livestock
  • 7.2.3. By Function
  • 7.2.4. By Form
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Eubiotics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Livestock
      • 7.3.1.2.3. By Function
      • 7.3.1.2.4. By Form
  • 7.3.2. France Eubiotics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Livestock
      • 7.3.2.2.3. By Function
      • 7.3.2.2.4. By Form
  • 7.3.3. United Kingdom Eubiotics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Livestock
      • 7.3.3.2.3. By Function
      • 7.3.3.2.4. By Form
  • 7.3.4. Italy Eubiotics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Livestock
      • 7.3.4.2.3. By Function
      • 7.3.4.2.4. By Form
  • 7.3.5. Spain Eubiotics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Livestock
      • 7.3.5.2.3. By Function
      • 7.3.5.2.4. By Form

8. Asia Pacific Eubiotics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Livestock
  • 8.2.3. By Function
  • 8.2.4. By Form
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Eubiotics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Livestock
      • 8.3.1.2.3. By Function
      • 8.3.1.2.4. By Form
  • 8.3.2. India Eubiotics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Livestock
      • 8.3.2.2.3. By Function
      • 8.3.2.2.4. By Form
  • 8.3.3. Japan Eubiotics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Livestock
      • 8.3.3.2.3. By Function
      • 8.3.3.2.4. By Form
  • 8.3.4. South Korea Eubiotics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Livestock
      • 8.3.4.2.3. By Function
      • 8.3.4.2.4. By Form
  • 8.3.5. Australia Eubiotics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Livestock
      • 8.3.5.2.3. By Function
      • 8.3.5.2.4. By Form

9. Middle East & Africa Eubiotics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Livestock
  • 9.2.3. By Function
  • 9.2.4. By Form
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Eubiotics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Livestock
      • 9.3.1.2.3. By Function
      • 9.3.1.2.4. By Form
  • 9.3.2. UAE Eubiotics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Livestock
      • 9.3.2.2.3. By Function
      • 9.3.2.2.4. By Form
  • 9.3.3. South Africa Eubiotics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Livestock
      • 9.3.3.2.3. By Function
      • 9.3.3.2.4. By Form

10. South America Eubiotics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Livestock
  • 10.2.3. By Function
  • 10.2.4. By Form
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Eubiotics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Livestock
      • 10.3.1.2.3. By Function
      • 10.3.1.2.4. By Form
  • 10.3.2. Colombia Eubiotics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Livestock
      • 10.3.2.2.3. By Function
      • 10.3.2.2.4. By Form
  • 10.3.3. Argentina Eubiotics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Livestock
      • 10.3.3.2.3. By Function
      • 10.3.3.2.4. By Form

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Eubiotics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Novozymes A/S
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Cargill, Incorporated
• 15.3. DuPont de Nemours, Inc.
• 15.4. Koninklijke DSM N. V.
• 15.5. Lallemand Inc.
• 15.6. Novus International, Inc.
• 15.7. Kemin Industries, Inc.
• 15.8. Asahi Group Holdings, Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer